News for Mind Medicine (MindMed) Inc (MMQ.F)

NeonMind Biosciences Inc. is pleased to announce that it has filed four new provisional patent applications with the United States Patent and Trademark Office to protect initial data obtained... | March 2, 2021

Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive Dr. Daniel R. Karlin

With a first-mover advantage in the field of psychedelics, shares of Mind Medicine (MindMed) Inc (NEO:MMED, OTCMKTS:MMEDF) are poised to climb significantly in 2021. The company has a strong product pipeline, it has launched a drug discovery partnership, and it recently raised $72.7 million.

TILT Hires Two Compliance Experts TILT Holdings Inc. (CSE:T...

MindMed (NEO: MMED) (OTCQB: MMEDF) agreed to buy HealthMode

Welcome to the Cannabis...

First Psychedelics ETF Debuts On NEO Exchange Psychedelics’ first exchange traded fund

/PRNewswire/ -- The ongoing surge of development and investment into psychedelic medicine and psychedelic-assisted therapy is the direct result of newfound...

Mind Medicine (MindMed) Inc (OTC: MMEDF), a medicine biotech company in psychedelics, on Wednesday announced its start of the first-ever clinical trial ...

Welcome to the Cannabis...